Chemomab Therapeutics News

Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(9.99%),OrbiMed Israel GP Ltd.(9.99%), etc.

Sep 16 16:37 ET

Chemomab Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sphera Funds Management Ltd.(6.56%),Sphera Global Healthcare GP Ltd.(6.56%), etc.

Aug 20 14:38 ET

Chemomab Therapeutics | D: Filing D

Aug 9 16:43 ET

Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(16.0%),OrbiMed Israel GP Ltd.(16.0%), etc.

Mar 11 19:23 ET

Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(18.3%),OrbiMed Israel GP Ltd.(18.3%), etc.

Nov 15, 2023 16:35 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Darvish Nissim

Jul 5, 2023 17:48 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Quigley Jill M.

Jun 20, 2023 06:03 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Fatal Sigal

Jun 16, 2023 16:03 ET

Chemomab Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Fatal Sigal

Jun 5, 2023 16:54 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Moses Alan Charles

Mar 23, 2023 07:38 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude

Mar 23, 2023 07:36 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cohen Neil Harris

Mar 23, 2023 07:35 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Darvish Nissim

Mar 23, 2023 07:33 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 5, 2023 16:49 ET

Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(19.7%),OrbiMed Israel GP Ltd.(19.7%)

Jan 5, 2023 16:31 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 5, 2023 16:01 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities

Nov 18, 2022 07:53 ET

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities

Nov 17, 2022 16:56 ET

Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adi Mor(6.4%),Kobi George(6.4%)

Nov 17, 2022 16:40 ET

Chemomab Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Frankel Matthew Bejosa

Nov 15, 2022 16:03 ET